These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9496253)

  • 1. The molecular pathology of urological malignancies.
    Dorkin TJ; Robson CN; Neal DE
    J Pathol; 1997 Dec; 183(4):380-7. PubMed ID: 9496253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of kidney tumours.
    Fleming S
    Forum (Genova); 1998; 8(2):176-84. PubMed ID: 9666053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer genetics: urological system. II.
    Lynch HT
    Nebr Med J; 1974 Dec; 59(12):460-5. PubMed ID: 4372563
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetics in urogenital cancer.
    Lynch HT; Walzak MP
    Urol Clin North Am; 1980 Oct; 7(3):815-29. PubMed ID: 6256928
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tumor inhibitory factors in urologic malignancies].
    Uemura H
    Hinyokika Kiyo; 2008 Jan; 54(1):49-52. PubMed ID: 18260361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular prognostic markers for urogenital cancers].
    Kubota Y
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):997-1003. PubMed ID: 8687235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of urological cancers.
    Maher ER
    Br Med Bull; 1994 Jul; 50(3):698-707. PubMed ID: 7987649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cancer genetics: von Hippel Lindau and other syndromes.
    Fleming S
    Int J Dev Biol; 1999; 43(5):469-71. PubMed ID: 10535326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour suppressor genes in urinary tract oncology.
    Brewster SF; Gingell JC; Brown KW
    Br J Urol; 1992 Dec; 70(6):585-90. PubMed ID: 1336697
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression and localization of HGF and met in Wilms' tumours.
    Alami J; Williams BR; Yeger H
    J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene expression in prostate cancer.
    Schalken JA; Bussemakers MJ; Debruyne FM
    Prog Clin Biol Res; 1990; 357():97-105. PubMed ID: 2217484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precancerous lesions in the kidney.
    Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
    Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
    Schulz S; Becker KF; Braungart E; Reichmuth C; Klamt B; Becker I; Atkinson M; Gessler M; Höfler H
    J Pathol; 2000 Jun; 191(2):162-9. PubMed ID: 10861576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder.
    Wang X; Zhang S; MacLennan GT; Eble JN; Lopez-Beltran A; Yang XJ; Pan CX; Zhou H; Montironi R; Cheng L
    Clin Cancer Res; 2007 Feb; 13(3):953-7. PubMed ID: 17289890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
    Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
    Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.